CN102406841A - Traditional Chinese medicine for treating tumors - Google Patents
Traditional Chinese medicine for treating tumors Download PDFInfo
- Publication number
- CN102406841A CN102406841A CN2011103941889A CN201110394188A CN102406841A CN 102406841 A CN102406841 A CN 102406841A CN 2011103941889 A CN2011103941889 A CN 2011103941889A CN 201110394188 A CN201110394188 A CN 201110394188A CN 102406841 A CN102406841 A CN 102406841A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- tumor
- medicine
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 49
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 33
- 241000208340 Araliaceae Species 0.000 claims abstract description 10
- 235000008434 ginseng Nutrition 0.000 claims abstract description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 9
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 9
- 241001250596 Pleione Species 0.000 claims abstract description 8
- 239000006187 pill Substances 0.000 claims abstract description 7
- 238000007796 conventional method Methods 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims abstract description 4
- 239000012567 medical material Substances 0.000 claims description 9
- 241001140314 Plestiodon chinensis Species 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 5
- 239000000796 flavoring agent Substances 0.000 claims description 4
- 235000019634 flavors Nutrition 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 230000000694 effects Effects 0.000 abstract description 10
- 238000002360 preparation method Methods 0.000 abstract description 10
- 210000004881 tumor cell Anatomy 0.000 abstract description 9
- 206010058467 Lung neoplasm malignant Diseases 0.000 abstract description 4
- 241000931191 Scincidae Species 0.000 abstract description 3
- 208000005718 Stomach Neoplasms Diseases 0.000 abstract description 3
- 210000004027 cell Anatomy 0.000 abstract description 3
- 206010017758 gastric cancer Diseases 0.000 abstract description 3
- 201000011549 stomach cancer Diseases 0.000 abstract description 3
- 206010006187 Breast cancer Diseases 0.000 abstract description 2
- 208000026310 Breast neoplasm Diseases 0.000 abstract description 2
- 238000012545 processing Methods 0.000 abstract description 2
- 239000003088 amphibian venom Substances 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 238000004140 cleaning Methods 0.000 abstract 1
- 230000003203 everyday effect Effects 0.000 abstract 1
- 201000007270 liver cancer Diseases 0.000 abstract 1
- 208000014018 liver neoplasm Diseases 0.000 abstract 1
- 201000005202 lung cancer Diseases 0.000 abstract 1
- 208000020816 lung neoplasm Diseases 0.000 abstract 1
- 238000011127 radiochemotherapy Methods 0.000 abstract 1
- 230000004083 survival effect Effects 0.000 abstract 1
- 238000005303 weighing Methods 0.000 abstract 1
- 206010003445 Ascites Diseases 0.000 description 4
- 238000002512 chemotherapy Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 230000002980 postoperative effect Effects 0.000 description 3
- 210000000582 semen Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102100023635 Alpha-fetoprotein Human genes 0.000 description 2
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 2
- 241000846172 Cremastra appendiculata Species 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 108010026331 alpha-Fetoproteins Proteins 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000002751 lymph Anatomy 0.000 description 2
- 210000004880 lymph fluid Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000831168 Alcedo pusilla Species 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 241000269417 Bufo Species 0.000 description 1
- 241001415440 Bufo gargarizans Species 0.000 description 1
- 241000269420 Bufonidae Species 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010016322 Feeling abnormal Diseases 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 101000914324 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 5 Proteins 0.000 description 1
- 101000914321 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 7 Proteins 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 208000007660 Residual Neoplasm Diseases 0.000 description 1
- 108010017842 Telomerase Proteins 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 208000009956 adenocarcinoma Diseases 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000005809 anti-tumor immunity Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 238000002591 computed tomography Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000001394 metastastic effect Effects 0.000 description 1
- 206010061289 metastatic neoplasm Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000002271 resection Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a traditional Chinese medicine for treating tumors. The traditional Chinese medicine is prepared from the following four medicine materials according to a mass ratio: 25 of toad venom, 25 of skink, 30 of pleione rhizome and 20 of ginseng. The preparation method of the traditional Chinese medicine comprises the steps of: weighing toad venom, skink, pleione rhizome and ginseng according to the mass ratio, cleaning, sunning, respectively grinding into fine powder, uniformly mixing, and processing into pills according to a conventional method, wherein each pill is 1g. The traditional Chinese medicine is taken orally twice every day and 2-3 pills each time. The traditional Chinese medicine is clinically applied and totally clinically treats more than 50 cases, and the result shows that the traditional Chinese medicine can directly destroy or kill tumor cells, reduce cells and shrink tumor bodies until the tumor bodies disappear, is effective to gastric cancer, lung cancer, liver cancer and mammary cancer, can improve physique, alleviate side effect of chemoradiotherapy, improve survival quality and prolong patient life, and has the curative rate about 80%. The traditional Chinese medicine is only made from four medicine materials, is simple and easy to obtain, is convenient for preparation, has obvious treatment effect and high curative rate, and is suitable for tumor patients.
Description
Technical field
The present invention is relevant with medicinal preparation, in particular to the medicine of treatment tumor.
Background technology
As everyone knows, tumor is one of human three big stupid diseases, and its mortality rate that causes is high; People are at the new therapy of constantly studying tumor; From present medical science, operation remains first-selected therapy, but it can't eliminate the tumor cell that is separated in blood or the lymph fluid; Simultaneously, also cause the recurrence of tumor, transfer to hide some dangers in the operation process easily.
Most authoritative tumor expert thinks; The antitumor immunity that eliminate postoperative residual tumor cell, improves patient's human body is that postoperative prevents the key that recurs, shift, clinically shows that medicine of the present invention can improve rapidly in a short time, the immunity of patient's human body; Rely on anticancer specially good effect composition simultaneously again; At first stop the formation and the absorption of tumor cell telomerase, cut off tumor cell and produce required energy supply, make its withered extinction through destroying a mouthful NA chain; Cut off tumour cell division, completely lose the conditions of existence and death.The supply of cut-out energy, the division of control tumor cell, the tumor body is dwindled in breeding; Collaborative operation not to the utmost, help cutting off the somatoblast of eliminating in tumor body and remaining blood or the lymph fluid; Effectively prevent post operative recurrence and transfer, and promote the wound immediate union, patient body is recovered rapidly.
In the oncotherapy, major part all will putting treatment, but chemicotherapy is in killing tumor cell; Also keep away the normal cell that unavoidably kills and wounds people's bulk-growth; Violent side effect reactions such as thereby the leukocyte that causes the patient descends, and is nauseating, according to data; There is nearly half tumor patient to die from the complication of chemicotherapy side effect, and is not tumor itself.
In recent years; Utilize the medicine for treating tumor thing of Chinese crude drug preparation existing hundreds of; For example one Chinese patent application part CN101204528 number " Chinese medicine preparation of treatment tumor ", CN101125178 number " a kind of Chinese medicine that is used to treat tumor ", CN101757562A number " a kind of Chinese medicine composition of treating liver malignant tumor in mid-term disease and preparation method thereof " etc.; Disclose some respectively and utilized the medicine of Chinese crude drug preparation, their curative effect does not still have report.But the medical material kind of these medicines is all a lot, is difficult to during use assort.
Summary of the invention
The object of the invention just is to provide a kind of Chinese medicine of treating tumor, to increase the types of drugs of treatment tumor, enables the service into the patient.
It is theoretical and to the research of plant amedica, the prescription that preferably comes out that the present invention is based on Chinese medicine.
The Chinese medicine of treatment tumor of the present invention is formulated by following 4 flavor medical materials, according to the prescription of quality proportioning is: Venenum Bufonis 25, Eumeces Chinensis 25, Pseudobulbus Cremastrae Seu Pleiones 30, Radix Ginseng 20.
In the above-mentioned medical material:
Venenum Bufonis be Bufonidae animal Bufo siccus (
Bufo bufo gargarizans) excretory white serosity, the medical material of dry processing, sweet little hardship, temperature, poisonous, can detoxify, detumescence, heart tonifying, pain relieving (the new medical college in Zhejiang. Chinese medicine voluminous dictionary: the 2714-2716 page or leaf);
Eumeces Chinensis, for Scincidae animal Eumeces Chinensis (
Eumeces chinensis) all, salty, cold, poisonous, can break knot, capable water (Chinese medicine voluminous dictionary: the 2714-2716 page or leaf);
Pseudobulbus Cremastrae Seu Pleiones, for the orchid Cremastra appendiculata (
Cremastra variabilis) the soccer fraud stem, Gan Weixin, cold, can detumescence, eliminating stagnation, (Chinese medicine voluminous dictionary: the 201-202 page or leaf) reduces phlegm, detoxifies;
Radix Ginseng, for the Araliaceae Radix Ginseng (
Panax ginseng) root, sweet little hardship, temperature, strongly invigorating primordial QI promotes the production of body fluid admittedly take off, (the Chinese medicine voluminous dictionary: the 29-36 page or leaf) of calming the nerves.
The preparation method of Chinese medicine of treatment tumor of the present invention is: according to the mass ratio of prescription get Venenum Bufonis, Eumeces Chinensis, Pseudobulbus Cremastrae Seu Pleiones, Radix Ginseng totally 4 flavor medical materials pick only, dry and be ground into fine powder respectively, mix homogeneously is processed pill according to conventional method, every ball 1g promptly gets.
The inventor points out that this medicine also can be processed capsule or other dosage form according to conventional method.
The Chinese medicine method for using of treatment tumor of the present invention is oral, 2 times on the one, and each 2～3 balls.
The Chinese medicine of treatment tumor of the present invention is in clinical acquisition test application, example surplus the clinical treatment 50 altogether, and the result shows; This medicine can directly destroy or the kill tumor cell, reduces cell and dwindle the tumor body directly to cause disappearance; Effective to gastric cancer, pulmonary carcinoma, hepatocarcinoma, breast carcinoma, can improve body constitution, alleviate the side effect of chemicotherapy; Improve life quality, prolong patient's life, cure rate is about 80%.
Only 4 kinds of the used medical materials of the Chinese medicine of treatment tumor of the present invention, be simple and easy to, preparation is convenient, and curative effect is obvious, and cure rate is high.Be applicable to tumor patient.
Typical clinical case has:
Case l Li Yuan land, man, 50 years old, Bijie City Cha He people from town, phone 0857-8463212.
Find stomach pain in January, 2003, feels bad, and finds that through hospital gastroscope stomach has a lump (5X3cm) to be diagnosed as gastric cancer; Do the stomach resection operation subsequently, and under doctor's suggestion, begun to do chemotherapy; But the side effect of chemotherapy is big; Untoward reaction such as vomiting, alopecia occur, body weight descends rapidly, leukopenia to 1800.Through check for the first time, lymph metastasis obviously appears in whole abdominal cavity, Semen Phaseoli grain size, and body has a spot of ascites, and carcinoembryonic antigen is greater than normal value; Glycosuria antigen also is higher than normal value far away, after take this medicine after one month, carry out second time check, the result shows; Leukocyte is raised to 5600 from 1800, and moreover, the carcinoembryonic antigen index decreased is near normal value, and ascites disappears; Body weight increases to some extent, and takes this medicine, and the result of check shows for the third time, abdominal cavity Semen Phaseoli grain appearance lymph complete obiteration; Carcinoembryonic antigen CEA drops to 5.4ig/ml, and sugar antigen drops to 6.1 ig/ml, and all indexs are normal fully, follows up a case by regular visits to not recurrence.
Case 2 second childs Xu, man, 36 years old, Lupanshui City Zhongshan District people, phone: 13324684946.
Find cough for several days in succession in April, 2004 constantly, chest pain is felt bad sometimes, and taking medicine has an injection loses effect; After hospital's CT examination finds that there is shade in pulmonary, pulmonary carcinoma is confirmed as in repeated multiple times inspection again; Accepted the chemotherapy of three courses of treatment subsequently in hospital, the state of an illness alleviates to some extent.Soon, find head pain day by day again, visual deterioration is forced in time and is in hospital, and is diagnosed as the vertigo that pulmonary carcinoma causes and moves.After take this medicine January, inspection finds that the brain metastatic lesion dwindles the head pain relief to some extent.After serveing on three months, all are normal for health.
Case 3 Ceng Yuanbi, woman, 42 years old, Pan county, Guizhou Province four lattice village people, phone: 0858-8290978.
Find that the stomach downside has pain in May, 2007; After hospital's CT scan inspection is primary hepatocarcinoma, right liver back segment has tumor body size 3.5cm * 2.5cm * 4.1cm, in the hospitalization; Symptoms such as ascites, liver cirrhosis have appearred; The albumin ratio seriously is inverted, and earns a bare living by defeated albumin, and body weight obviously descends.After take this medicine after, just took a turn for the better to some extent in more than ten day.Serve on after two months, ascites obviously disappears, and liver function each item index becomes normally, and AFP (alpha-fetoprotein) drops to 12.12ng/ml by original 97.1lng/ml, and lump is 1.8 * 2.0 * 1.9cm, is hidden by iodized oil, follows up a case by regular visits to the people and also survives.
The little kingfisher of case 4 Korea Spro, woman, 42 years old, lake, Bijie City people from street.
The patient finds that in February, 2002 right breast has the big swollen thing of an egg, and Kweiyang hospital does pathology inspection, is reported as adenocarcinoma of breast, after do radical operation, and make one month chemotherapy.After half a year, the big swollen thing of Semen Juglandis appears again in right breast, and cervical region also has the rigid swollen thing that differs in size, and goes to Kweiyang to seek medical advice immediately again, is diagnosed as cancerous protuberance and extensively shifts, and can't cure.In going back home, upon somebody's introduction, the patient takes this medicine, and appetite heightens after one month, and swollen thing obviously diminishes, and spirit is gradually good; After the bimester of taking medicine, swollen thing complete obiteration, weight increase 7.5kg.After taking medicine three months, remove examination in hospital, not seeing has unusually.It is also alive to follow up a case by regular visits to the people, and the manual labour of going out.
The specific embodiment
Embodiment treats the Chinese medicine of tumor according to the following step preparation:
Get Venenum Bufonis 50g, Eumeces Chinensis 50g, Pseudobulbus Cremastrae Seu Pleiones 60g, Radix Ginseng 40g
Above-mentioned medical material is picked only, dries and be ground into fine powder respectively, and mix homogeneously is processed pill according to conventional method, and every ball 1g promptly gets the Chinese medicine of 200 pill for curing tumors.
Claims (3)
1. Chinese medicine of treating tumor is characterized in that this Chinese medicine is formulated by following 4 flavor medical materials, according to the prescription of quality proportioning is: Venenum Bufonis 25, Eumeces Chinensis 25, Pseudobulbus Cremastrae Seu Pleiones 30, Radix Ginseng 20.
2. the method for preparing the Chinese medicine of the described treatment tumor of claim 1; It is characterized in that according to the mass ratio of prescription get Venenum Bufonis, Eumeces Chinensis, Pseudobulbus Cremastrae Seu Pleiones, Radix Ginseng totally 4 flavor medical materials pick only, dry and be ground into fine powder respectively, mix homogeneously is processed pill according to conventional method; Every ball 1g promptly gets.
3. the method for using of the Chinese medicine of the described treatment tumor of claim 1 is oral when it is characterized in that using, and 2 times on the one, each 2～3 balls.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110394188.9A CN102406841B (en) | 2011-12-02 | 2011-12-02 | Traditional Chinese medicine for treating tumors |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110394188.9A CN102406841B (en) | 2011-12-02 | 2011-12-02 | Traditional Chinese medicine for treating tumors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102406841A true CN102406841A (en) | 2012-04-11 |
| CN102406841B CN102406841B (en) | 2014-03-05 |
Family
ID=45909376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201110394188.9A Expired - Fee Related CN102406841B (en) | 2011-12-02 | 2011-12-02 | Traditional Chinese medicine for treating tumors |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102406841B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108619452A (en) * | 2018-05-18 | 2018-10-09 | 杜美丽 | It a kind of Chinese medicine composition that treating tumour and follows through permeabilization therapy |
| CN111956757A (en) * | 2020-08-21 | 2020-11-20 | 夏荣全 | Anticancer compound wine with homology of medicine and food |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1094620A (en) * | 1993-04-17 | 1994-11-09 | 刘学勤 | The Chinese patent medicine Liu Hua ai huixiangdan of the treatment esophageal carcinoma |
| CN1216704A (en) * | 1997-11-04 | 1999-05-19 | 张士舜 | Injection for anti-tumor |
| CN1235041A (en) * | 1999-01-08 | 1999-11-17 | 徐建华 | Medicinal composition for cancers |
| CN1872284A (en) * | 2006-04-25 | 2006-12-06 | 段汝钦 | Chinese traditional medicine for treating breast cancer |
| CN1970042A (en) * | 2006-12-08 | 2007-05-30 | 胡冬林 | Chinese herbal capsule for reducing cancerous protuberance and dispelling toxins |
| CN102008650A (en) * | 2010-12-16 | 2011-04-13 | 天津市医药科学研究所 | Compound traditional Chinese medicine preparation for treating tumors and preparation method thereof |
-
2011
- 2011-12-02 CN CN201110394188.9A patent/CN102406841B/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1094620A (en) * | 1993-04-17 | 1994-11-09 | 刘学勤 | The Chinese patent medicine Liu Hua ai huixiangdan of the treatment esophageal carcinoma |
| CN1216704A (en) * | 1997-11-04 | 1999-05-19 | 张士舜 | Injection for anti-tumor |
| CN1235041A (en) * | 1999-01-08 | 1999-11-17 | 徐建华 | Medicinal composition for cancers |
| CN1872284A (en) * | 2006-04-25 | 2006-12-06 | 段汝钦 | Chinese traditional medicine for treating breast cancer |
| CN1970042A (en) * | 2006-12-08 | 2007-05-30 | 胡冬林 | Chinese herbal capsule for reducing cancerous protuberance and dispelling toxins |
| CN102008650A (en) * | 2010-12-16 | 2011-04-13 | 天津市医药科学研究所 | Compound traditional Chinese medicine preparation for treating tumors and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 龙泳伶等: "中医治则指导下抗肿瘤中药的临床分类", 《中国中医药现代远程教育》, no. 12, 30 June 2011 (2011-06-30) * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108619452A (en) * | 2018-05-18 | 2018-10-09 | 杜美丽 | It a kind of Chinese medicine composition that treating tumour and follows through permeabilization therapy |
| CN111956757A (en) * | 2020-08-21 | 2020-11-20 | 夏荣全 | Anticancer compound wine with homology of medicine and food |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102406841B (en) | 2014-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102342992B (en) | Chinese medicinal composition for treating insomnia and preparation method of preparation thereof | |
| CN103041317B (en) | A kind of Chinese medicine composition for the treatment of tumor and preparation method thereof | |
| CN103431260B (en) | Mixed-grain full-nutrition formulation food for patients with gastrointestinal tract malabsorption and pancreatitis | |
| CN102406841B (en) | Traditional Chinese medicine for treating tumors | |
| CN102205035A (en) | Traditional Chinese medicine for treating gastric cancer | |
| CN101991804B (en) | Externally applied medicament for treating stomach illness | |
| CN105664027A (en) | Traditional Chinese medicine pills for treating thyroid cancer and preparing method thereof | |
| CN101455702B (en) | Traditional Chinese medicinal preparation for treating cancer | |
| CN104623605A (en) | Traditional Chinese medicine capable of treating breast cancer | |
| CN101264279B (en) | Chinese medicinal composition for treating common cancer and producing method thereof | |
| CN104888128A (en) | Traditional Chinese medicine composition for treatment of cancers | |
| CN104707110A (en) | Traditional Chinese medicine preparation for treating pancreatic cancer and preparation method thereof | |
| CN104435522A (en) | Compound preparation for treating duodenal ulcer and preparation method thereof | |
| CN1222364A (en) | Serial medicines for curing cancer through oral taking, dressing and medicated diet and preparation thereof | |
| CN103520341A (en) | Traditional Chinese medicine prescription used for treating esophageal cancer | |
| CN102302742B (en) | Traditional Chinese medicine composition for treating cardiac cancer and esophageal cancer | |
| CN102430054B (en) | Applications of traditional Chinese medicinal compound preparation for removing toxicity, resisting cancer, activating blood and dissipating mass | |
| CN101780204A (en) | Traditional Chinese medicine for treating tumors - quick-effect scabrousstem greenbrier rhizome and caulis mayteni root-bark powder | |
| CN104491264A (en) | Heat and toxic material clearing preparation for treating esophageal cancer and preparation method of heat and toxic material clearing preparation | |
| CN104096172A (en) | Traditional Chinese medicine preparation capable of resisting malignant tumors | |
| CN105582301A (en) | Side reaction-resistant paste for postoperative patient with tumor | |
| CN110613744A (en) | Traditional Chinese medicine composition for treating breast cancer liver metastasis and preparation method and application thereof | |
| CN110237183A (en) | The Chinese medicine composition and preparation method thereof of health and cancer preventing and treating | |
| CN104027659A (en) | Traditional Chinese medicine particle for treating hiatus hernia and preparing method thereof | |
| CN102302759B (en) | Medicament for treating chronic gastritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20170126 Address after: 551801 No. 174 Changan Road, Jinsha County, Guizhou, China No. 5 Patentee after: Guizhou Hongde Traditional Chinese Medicine Development Co., Ltd. Address before: 553001 Liupanshui Province, Zhongshan City, Guizhou Province, Wang Hai Road, No. 50 attached to No. 7 Patentee before: Gong Dingjun |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140305 Termination date: 20171202 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |